COL8A1
COL8A1 (collagen type VIII alpha 1 chain) encodes one of the two alpha chains of type VIII collagen, a short chain collagen found in the extracellular matrix. It is also known as C3orf7 and MGC9568, and its C-terminal fragment, vastatin, has anti-proliferative activity on endothelial cells. Browse Assay Genie's current range of COL8A1 research reagents below, or read on for the biology behind the target.
The COL8A1 gene encodes one of the two alpha chains of type VIII collagen. The gene product is a short chain collagen and a major component of the basement membrane of the corneal endothelium. Type VIII collagen fibrils can be assembled as either homotrimers or heterotrimers, and the protein is secreted into the extracellular space, where it becomes part of the extracellular matrix and basement membrane.
The C-terminal fragment of the chain, which comprises the NC1 domain, is known as vastatin. According to UniProt, vastatin inhibits aortic endothelial cell proliferation and causes apoptosis of these cells. This gives the COL8A1 protein a role beyond structural support, and makes it of interest in studies of endothelial biology and matrix-derived signalling fragments.
HGNC places the gene in two groups: the C1q domain containing proteins and the network forming collagens. Alternatively spliced transcript variants have been observed, and these encode the same protein. The gene was previously designated chromosome 3 open reading frame 7 (C3orf7), and earlier nomenclature referred to it as collagen, type VIII, alpha 1. The mouse ortholog is Col8a1, and the other type VIII alpha chain is encoded by COL8A2.
COL8A1 is a major component of the basement membrane of the corneal endothelium, making it a relevant marker for studies of matrix structure.
As a major basement membrane collagen of the corneal endothelium, type VIII collagen is studied in the context of corneal tissue organisation.
The vastatin fragment inhibits aortic endothelial cell proliferation and induces apoptosis, supporting work on matrix-derived regulators of endothelial growth.
Type VIII collagen forms homo- or heterotrimers, so COL8A1 is used to examine chain composition and network formation among short chain collagens.
COL8A1 encodes one of the two alpha chains of type VIII collagen, a short chain collagen that is a major component of the basement membrane of the corneal endothelium. Its C-terminal NC1 fragment, vastatin, inhibits aortic endothelial cell proliferation and causes apoptosis.
COL8A1 is also called C3orf7 and MGC9568, and was previously named chromosome 3 open reading frame 7 and collagen, type VIII, alpha 1. The UniProt protein name is collagen alpha-1(VIII) chain. Alternatively spliced transcript variants have been observed, and they encode the same protein.
A mouse ortholog, Col8a1, is recorded for this gene. Type VIII collagen is assembled from two alpha chains, COL8A1 and COL8A2, which can form homotrimers or heterotrimers. Check the datasheet of any product for its validated reactivity.
Other collagen chains, including COL8A2 and further network-forming and basement membrane collagens, plus related C1q domain proteins.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P27658; product specifications from Assay Genie datasheets.